STOCK-BASED COMPENSATION (Tables)

12 Months Ended

Dec. 31, 2021

Schedule of assumptions used for estimated fair value of employee stock options granted

Expected volatility		90	%
Common stock value	$	5.6-$33.7
Risk free interest rate		0.06	%
Expected dividend yield		—
Expected term (years)		6.25

Schedule of outstanding unvested stock activities

	Unvested
	Common
	Stock
Balances outstanding at December 31, 2020	450,424
New grants or issues	834,883
Common stock vested	(448,773)
Repurchased stock	(21,651)
Balances outstanding at December 31, 2021	814,883

Schedule of stock-based compensation expense recognized for both employees and non-employees

	2021		2020
Sales and marketing	$	67,119	$	22,805
Research and development		369,434		—
General and administrative		63,315		5,339
Total stock-based compensation expense	$	499,868	$	28,144

Stock Option Activity [Member]

Schedule of stock option activity

	Options Outstanding
				Weighted
		Weighted		Average
		Average		Remaining
		Exercise		Contractual	Aggregate
	Number of	Price Per		Term	Intrinsic
	Options	Share		(in years)	Value
Balance as of December 31, 2019	85,000	$	0.63	8.48	$	623,100
Stock options granted	—		—
Stock options exercised	—		—
Stock options forfeited, canceled, or expired	—		—
Balance as of December 31, 2020	85,000	$	0.63	7.48	$	422,500
Stock options granted	168,500		6.01
Stock options exercised	(55,000)		0.10		$	302,500
Stock options forfeited, cancelled, or expired	—		—
Balance as of December 31, 2021	198,500		5.35	9.11	$	7,024,429
Options exercisable as of December 31, 2021	95,544		4.40	8.76	$	3,471,200
Options vested and expected to vest as of December 30, 2021	198,500	$	5.35	9.11	$	7,024,429

Restricted Stock Units (RSUs) [Member]

Schedule of stock option activity

		Weighted Average
		Grant Date Fair
		Value
	Share	per Share
Balance as of December 31, 2020	—	$	—
Restricted Stock units granted	910,867		14.33
Restricted Stock units forfeited	—		—
Restricted Stock units vested	—		—
Balance as of December 31, 2021	910,867	$	14.33